| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.07B | $2.94B | $3.40B |
| YoY Revenue Growth % | +4.5% | -13.7% | — |
| Gross Profit | $594.9M | $626.3M | — |
| Gross Margin % | 19.4% | 21.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $56.9M | $5.6M | $486.1M |
| Operating Margin % | 1.9% | 0.2% | 14.3% |
| Net Income (GAAP) | -$9.0M | -$31.2M | $323.8M |
| EBITDA (Normalized) | $167.4M | $111.4M | $608.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $184.3M | $173.7M | $365.7M |
| Capital Expenditures (CapEx) | $138.1M | $132.2M | $153.1M |
| Free Cash Flow (FCF) | $46.2M | $41.5M | $212.6M |
| FCF Margin % | 1.5% | 1.4% | 6.2% |
| Return on Invested Capital (ROIC %) | 1.8% | 0.2% | 15.6% |
| Cash & Short-Term Equivalents | $515.0M | $590.3M | — |
| Total Debt (Short + Long Term) | $950.9M | $905.0M | $955.3M |
| Total Stockholders' Equity | $2.09B | $2.03B | $1.96B |